Results 51 to 60 of about 42,031 (222)

Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling

Advanced Healthcare Materials, EarlyView.
Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...
Tanmay Mukherjee, Mehdi Salar Amoli, Sarah Rezapourdamanab, Lama Rita El Shammas, Martin L. Tomov, Emilio A. Mendiola, Vahid Serpooshan, Reza Avazmohammadi   +7 more
wiley   +1 more source

Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement [PDF]

, 2016
The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven.
Makdisi, George, Makdisi, Peter B., Wang, I-Wen   +2 more
core   +1 more source

A Soft Robotic Model for Simulating Heart Valve Disease and Cardiac Interventions

Advanced Science, EarlyView.
This paper introduces a fully synthetic fabrication methodology for a soft robotic, in‐vitro model of the left‐heart, complete with a functioning mitral valve apparatus. With a view towards patient‐specific modeling, we demonstrate physiological flow and pressure waveforms, tunable mitral valve function with clinical imaging compatibility, and its use ...
James Davies, Emanuele Nicotra, Kefan Zhu, Chi Cong Nguyen, Bibhu Sharma, Adrienne Ji, Phuoc Thien Phan, Jingjing Wan, Patrick Pruscino, Hermione Truong, Jelena Rnjak‐Kovacina, Hoang‐Phuong Phan, Christopher Hayward, Nigel Hamilton Lovell, Thanh Nho Do   +14 more
wiley   +1 more source

Transcatheter Aortic Valve Replacement for Aortic Stenosis With Prosthetic Mitral Paravalvular Leak and Hemolytic Anemia

JACC: Case Reports, 2020
This report describes a successful transcatheter aortic valve replacement in an older patient with severe aortic stenosis, mitral paravalvular leak, and associated hemolytic anemia.
Hideaki Kanzaki, MD, PhD, Yusuke Shimahara, MD, PhD, Makoto Amaki, MD, PhD, Atsushi Okada, MD, PhD, Tomoyuki Fujita, MD, PhD, Chisato Izumi, MD, PhD, Satoshi Yasuda, MD, PhD, Junjiro Kobayashi, MD, PhD   +7 more
doaj   +1 more source

Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. [PDF]

, 2017
Aims: The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve implantation (TAVI) with a self-expanding bioprosthesis in real-world patients with symptomatic, severe aortic stenosis at high surgical risk for ...
Adams, Axel Linke, Barbanti, Bosmans, Brecker, Corrado Tamburino, Deeb, Duncan, Egbe, Grube, Jia Guo, Johan Bosmans, Joint Task Force on the Management of Valvular Heart Disease of the European Society of (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Kapadia, Kappetein, Kleiman, Leon, Leon, Leon, Linke, Mack, Makkar, Makkar, Peter Wenaweser, Piazza, Popma, Reardon, Sabine Bleiziffer, Sondergaard, Sondergaard, Stephen Brecker, Ulrich Gerckens, Van Belle, Yakubov   +33 more
core   +1 more source

Valve Thrombosis After Transcatheter Aortic Valve Replacement

Journal of the American College of Cardiology, 2017
Transcatheter aortic valve replacement (TAVR) is the standard of care for patients with severe aortic stenosis who are increased risk for open heart surgery. Currently more than 200,000 patients worldwide have received this therapy, and the majority of implanted valves have shown no evidence ...
Femi, Philip, Howard, Dinh, John, Ko, Micheal I, Chow, Joseph, Huh   +4 more
openaire   +2 more sources

Pathogenic PF4/Polyanion ELISA‐Negative Antibodies in HIT

American Journal of Hematology, EarlyView.
ABSTRACT Background Platelet factor 4‐polyanion enzyme‐linked immunosorbent assays (ELISAs) are considered highly sensitive for diagnosing heparin‐induced thrombocytopenia (HIT), such that current practice guidelines recommend use of ELISA‐negative results to exclude HIT.
Adam J. Kanack, Noah P. Splinter, Emily E. Mauch, Leben Tefera, Morayma Reyes Gil, Sakshi Jasra, Andrew Goodwin, Kristi J. Smock, Hadiyah Ahmad, Aneel Ashrani, Nathaniel L. Robinson, Ana I. Casanegra, Curtis G. Jones, Shannon M. Pechauer, Erin Yttre, Richard H. Aster, Mindy C. Kohlhagen, Rachel R. Leger, Gretchen Johns, David L. Murray, Lu Zhou, Demin Wang, Renren Wen, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan   +25 more
wiley   +1 more source

Predicting Coronary Occlusion Risk during Redo‐TAVR at First TAVR: Asymmetric Calcification Causes Failure

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aims Predicting coronary artery occlusion due to sinus sequestration (SS) during a second transcatheter aortic valve (TAV) procedure using pre‐procedural computed tomography (CT) after the first TAV replacement (TAVR) is underreported.
Kyohei Onishi, Masakazu Yasuda, Nobuhiro Yamada, Naoko Soejima, Ayano Yoshida, Kosuke Fujita, Hiroki Matsuzoe, Tatsuya Miyoshi, Koichiro Matsumura, Kazuki Mizutani, Masafumi Ueno, Genichi Sakaguchi, Gaku Nakazawa   +12 more
wiley   +1 more source

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico, Locca, Didier, Marcucci, Carlo, Niclauss, Lars   +3 more
core  

Transcatheter aortic valve implantation in 2015 [PDF]

, 2016
Not ...
FATTOUCH, Khalil, Modine, T., Moscarelli, M., Mylotte, D., PIAZZA, Nicolo', Sharif, F.   +5 more
core   +2 more sources